To halt brain diseases, drugs take aim at protein traffic jams that kill neurons
Elie Dolgin • January 16, 2019
Compound that normalizes flow of proteins in cells will now be tested in a clinical trial for ALS
Continue reading at Science Magazine.
The detailed scans could inspire robots and biomechanical designs.
But the rise of robots and AI may disrupt the sport’s ethos.